TOPLUM ECZACILARININ BİRİNCİ BASAMAK SAĞLIK HİZMETLERİNE ENTEGRE EDİLMESİ: TÜRKİYE İÇİN BİR POLİTİKA ÖNERİSİ

Öz

Amaç: Toplum eczacılığı hizmeti, son yıllarda ilaç satış ve dağıtımının ötesine geçerek farmasötik bakım odaklı hale gelmiştir. Toplum eczaneleri, en kolay erişilebilir durumdaki sağlık profesyoneli grubu olması sebebiyle pekçok kişi için sağlık hizmetlerinde ilk ve bazen de tek temas noktası haline gelmiştir. Sağlık insangücü eksikliği, nüfusun yaşlanması, kronik hastalıkların artması gibi pekçok faktör sağlık sistemlerinde birinci basamak sağlık hizmetlerinin sunumu konusunda baskı oluşturmaktadır. Bazı ülkeler birinci basamak sağlık hizmetlerinin sunumunu rahatlatabilmek için toplum eczacılarından daha fazla yararlanmaya başlamıştır. Bu kapsamda, birinci basamak sağlık hizmetlerinde dünya genelinde eczacıların rolünün genişlediği görülmektedir. Bu çalışmanın amacı, toplum eczacılarının birinci basamak sağlık hizmetlerinde aktif olarak kullanılması konusunu Türkiye düzleminde incelemektir. Sonuç ve Tartışma: Sonuç olarak, Türkiye’de toplum eczacılarının birinci basamak sağlık hizmetleri sisteminde aktif olarak yer almadığı görülmüştür. İlerleyen dönemlerde, mevcut ülke örneklerinin de incelenerek gerekli politik zeminin oluşturulmasıyla toplum eczacılarının birinci basamak sağlık hizmetleri sunumuna aktif katılımlarının sağlanabileceği düşünülmektedir.

Anahtar Kelimeler

• Birinci basamak sağlık hizmetleri
• sağlık politikası
• toplum eczacılığı

INTEGRATION OF COMMUNITY PHARMACISTS INTO PRIMARY HEALTH SERVICES: A POLICY RECOMMENDATION FOR TURKEY

Öz

Objective: In recent years, the community pharmacy profession has moved beyond the sale and distribution of drugs to become pharmaceutical care oriented. Community pharmacies have become the first and sometimes the only point of contact in healthcare for many people, as they are the most easily accessible group of healthcare professionals. Many factors such as lack of health manpower, aging of the population, increase in chronic diseases put pressure on the provision of primary healthcare services in health systems. Some countries have started to benefit more from community pharmacists in order to ease the delivery of primary healthcare services. In this context, it is seen that the role of pharmacists in primary healthcare services is expanding worldwide. The aim of this study is to examine the active use of community pharmacists in primary healthcare services in Turkey. Result and Discussion: As a result, it has been observed that community pharmacists are not actively involved in the primary healthcare system in Turkey. In the following periods, it is thought that the active participation of community pharmacists in the provision of primary healthcare services can be ensured by examining the existing country examples and establishing the necessary political ground.

Anahtar Kelimeler

• Community pharmacy
• health policy
• primary care

Kaynakça

1. 1. World Health Organization Web site. (2016). Retrieved May 19, 2016, from https://www.who.int/gho/publications/world_health_statistics/2016/en/. Erişim tarihi: 26.08.2023.
2. 2. Ramos, H., Pardo, J., Sánchez, R., Puchades, E., Pérez-Tur, J., Navarro, A., Moreno, L. (2021). Pharmacist-physician interprofessional collaboration to promote early detection of cognitive impairment: increasing diagnosis rate. Frontiers in Pharmacology, 12, 579489. [CrossRef]
3. 3. Mossialos, E., Courtin, E., Naci, H., Benrimoj, S., Bouvy, M., Farris, K., Noyce, P., Sketris, I. (2015). From “retailers” to health care providers: transforming the role of community pharmacists in chronic disease management. Health Policy, 119(5), 628-639. [CrossRef]
4. 4. Worley, M.M., Schommer, J.C., Brown, L.M., Hadsall, R.S., Ranelli, P.L., Stratton, T.P., Uden, D.L. (2007). Pharmacists' and patients' roles in the pharmacist-patient relationship: are pharmacists and patients reading from the same relationship script? Research in Social and Administrative Pharmacy, 3(1), 47-69. [CrossRef]
5. 5. Hepler, C.D., Strand, L.M. (1990). Opportunities and responsibilities in pharmaceutical care. American Journal of Hospital Pharmacy, 47(3), 533-543. [CrossRef]
6. 6. FIP (2021). Serbest eczacılığa genel bir bakış. İlaçların serbest eczaneler ve diğer noktalar aracılığıyla dağıtımının hukuki çerçevesi, uygulama kapsamı ve ücretlendirilmesi, from https://dergi.tebeczane.net/public_html/kitaplar/serbesteczaciligagenel/html5/index.html?&locale=TRK. Erişim tarihi: 25.08.2023
7. 7. Nkansah, N., Mostovetsky, O., Yu, C., Chheng, T., Beney, J., Bond, C.M., Bero, L. (2010). Effect of outpatient pharmacists' non‐dispensing roles on patient outcomes and prescribing patterns. Cochrane Database of Systematic Reviews, 7. [CrossRef]
8. 8. Nussbaumer-Streit, B., Mayr, V., Dobrescu, A.I., Chapman, A., Persad, E., Klerings, I., Wagner, G., Siebert, U., Christof, C., Zachariah, C., Gartlehner, G. (2020). Quarantine alone or in combination with other public health measures to control COVID‐19: A rapid review. Cochrane Database of Systematic Reviews, 9, 1-78. [CrossRef]

9. 9. TEB (2022). Sağlığa Yol Açan Eczacılık, Türk Eczacıları Birliği Yayınları, Ankara, p.51.
10. 10. Eades, C.E., Ferguson, J.S., O'Carroll, R.E. (2011). Public health in community pharmacy: A systematic review of pharmacist and consumer views. BMC Public Health, 11, 1-13. [CrossRef]
11. 11. The Pharmacy Guild of Australia Web site. (2010). Retrieved February, 2010, from https://www.guild.org.au/__data/assets/pdf_file/0026/4769/here-.pdf. Erişim tarihi: 25.08.2023.
12. 12. Clark, A., Roughead, L. (2012). Pharmacist perspectives on managing older patients with multiple chronic conditions. Australian Pharmacist, 31(2), 148-153.
13. 13. Lamberts, E.J., Bouvy, M.L., van Hulten, R.P. (2010). The role of the community pharmacist in fulfilling information needs of patients starting oral antidiabetics. Research in Social and Administrative Pharmacy, 6(4), 354-364. [CrossRef]
14. 14. Awad, A., Abahussain, E. (2010). Health promotion and education activities of community pharmacists in Kuwait. Pharmacy World & Science, 32, 146-153. [CrossRef]
15. 15. FIP Web site. (2005). Retrieved September, 2003, from https://www.fip.org/file/1468. Erişim tarihi: 27.08.2023.
16. 16. Okoro, R.N., Nduaguba, S.O. (2021). Community pharmacists on the frontline in the chronic disease management: The need for primary healthcare policy reforms in low and middle income countries. Exploratory Research in Clinical and Social Pharmacy, 2, 100011. [CrossRef]
17. 17. Chukwu, O.A. (2020). Beyond medicines provision: community pharmacists roles in meeting patient needs through value-added pharmacy services. Journal of Pharmaceutical Health Services Research, 11(3), 299-301. [CrossRef]
18. 18. Moullin, J.C., Sabater-Hernández, D., Fernandez-Llimos, F., Benrimoj, S.I. (2013). Defining professional pharmacy services in community pharmacy. Research in Social and Administrative Pharmacy, 9(6), 989-995. [CrossRef]
19. 19. Malone, D.C., Rascati, K.L., Gagnon, J.P. (1993). Consumers' evaluation of value-added pharmacy services. American Pharmacy, 33(3), 48-56. [CrossRef]
20. 20. Poh, E.W., McArthur, A., Stephenson, M., Roughead, E.E. (2018). Effects of pharmacist prescribing on patient outcomes in the hospital setting: a systematic review. JBI Evidence Synthesis, 16(9), 1823-1873. [CrossRef]
21. 21. Hoti, K., Hughes, J., Sunderland, B. (2011). An expanded prescribing role for pharmacists-an Australian perspective. The Australasian Medical Journal, 4(4), 236-242. [CrossRef]
22. 22. Nissen, L., Kyle, G., Stowasser, D.A., Lum, E., Jones, A., McLean, C. (2010). Non-medical prescribing. Australian Health Workforce Institute, Collaboration National Health Workforce, Retrieved June 1, 2010, from http://www.ahwo.gov.au/documents/NHWT/Non%20Medical%20Prescribing%20Final%20Report.pdf.
23. 23. Emmerton, L., Marriott, J., Bessell, T., Nissen, L., Dean, L. (2005). Pharmacists and prescribing rights: Review of international developments. Journal of Pharmacy and Pharmaceutical Sciences, 8(2), 217-225.
24. 24. Smith, M., Giuliano, M.R., Starkowski, M.P. (2011). In Connecticut: Improving patient medication management in primary care. Health Affairs, 30(4), 646-654. [CrossRef]
25. 25. FIP (2012). Human resources the 2012 FIP global pharmacy workforce report, from https://www.fip.org/static/fipeducation/2012/FIP-Workforce-Report-2012/pages/7-fip-workforce-report-2012.html Erişim tarihi: 25.08.2023.
26. 26. Habeeb Ibrahim, A.R., Jose, D., Jegan, R.S. (2012). Pharmacists in the wider public health workforce-a review. Archives of Pharmacy Practice, 3(2), 166-169.
27. 27. Mossialos, E., Naci, H., Courtin, E. (2013). Expanding the role of community pharmacists: policymaking in the absence of policy-relevant evidence? Health Policy, 111(2), 135-148.
28. 28. Bush, J., Langley, C.A., Wilson, K.A. (2009). The corporatization of community pharmacy: implications for service provision, the public health function, and pharmacy's claims to professional status in the United Kingdom. Research in Social and Administrative Pharmacy, 5(4), 305-318. [CrossRef]
29. 29. Ihekoronye, M.R., Osemene, K.P. (2022). Evaluation of the participation of community pharmacists in primary healthcare services in Nigeria: A mixed-method survey. International Journal of Health Policy and Management, 11(6), 829-839. [CrossRef]
30. 30. Veillard, J., Cowling, K., Bitton, A., Ratcliffe, H., Kimball, M., Barkley, S., Mercereau, L., Wong, E., Taylor, C., Hirschhorn, L.R., Wang, H. (2017). Better measurement for performance improvement in Low‐and Middle‐Income countries: the primary health care performance Initiative (PHCPI) experience of conceptual framework development and indicator selection. The Milbank Quarterly, 95(4), 836-883. [CrossRef]
31. 31. Law, M.R., Dijkstra, A., Douillard, J.A., Morgan, S.G. (2011). Geographic accessibility of community pharmacies in Ontario. Healthcare Policy, 6(3), 36. [CrossRef]
32. 32. Hedima, E.W., Adeyemi, M.S., Ikunaiye, N.Y. (2021). WITHDRAWN: Community pharmacists: On the frontline of health service against COVID-19 in LMICs. Research in Social and Administrative Pharmacy, 17(1), 1964-1966. [CrossRef]
33. 33. Aruru, M., Truong, H.A., Clark, S. (2020). Pharmacy emergency preparedness and response (PEPR) Framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond. Research in Social & Administrative Pharmacy, 2, 1967-1977. [CrossRef]
34. 34. Dalton, K., Byrne, S. (2017). Role of the pharmacist in reducing healthcare costs: Current insights. Integrated Pharmacy Research and Practice, 6, 37-46. [CrossRef]
35. 35. Smith, F. (2009). Private local pharmacies in low‐and middle‐income countries: A review of interventions to enhance their role in public health. Tropical Medicine & International Health, 14(3), 362-372. [CrossRef]
36. 36. Dyfrig, H., Susan, M., Longo, M., Lisles, C. (2008). Investigating factors influencing user choices to visit either general practitioners or community pharmacists in the management of minor ailments-piloting a discrete choice experiment. Pharmacy Practice Research Trust, Retrieved March, 2008, from http://pharmacyresearchuk.org/wp-content/uploads/2012/11/Investigating_factors_influencing_user_choi ces.pdf.
37. 37. Smith, J., Rao, M. (2005). Choosing health through pharmacy: A programme for pharmaceutical public health. Scientific Research, 2(9), 04012.
38. 38. Petkova, V.B. (2009). Education for arthritis patients: A community pharmacy based pilot project. Pharmacy Practice, 7(2), 88. [CrossRef]
39. 39. Petkova, V.B. (2008). Pharmaceutical care for asthma patients: A community pharmacy-based pilot project. In Allergy & Asthma Proceedings, 29(1), 55-61. [CrossRef]
40. 40. Abdelhamid, E., Awad, A., Gismallah, A. (2008). Evaluation of a hospital pharmacy-based pharmaceutical care services for asthma patients. Pharmacy Practice, 6(1), 25-32. [CrossRef]
41. 41. Ebid, A.H.I., Abdel-Wahab, E. (2006). Bronchial asthma and COPD: Impact of pharmaceutical care on outcomes and quality of life in Egyptian patients. Bulletin of Pharmaceutical Sciences. Assiut, 29(1), 167-185. [CrossRef]
42. 42. Fielding, S., Porteous, T., Ferguson, J., Maskrey, V., Blyth, A., Paudyal, V., Barton, G., Holland, R., Bond, C.M., Watson, M.C. (2015). Estimating the burden of minor ailment consultations in general practices and emergency departments through retrospective review of routine data in North East Scotland. Family Practice, 32(2), 165-172. [CrossRef]
43. 43. Dey, R.M., de Vries, M.J., Bosnic-Anticevich, S. (2011). Collaboration in chronic care: Unpacking the relationship of pharmacists and general medical practitioners in primary care. International Journal of Pharmacy Practice, 19(1), 21-29. [CrossRef]
44. 44. McMillan, S.S., Wheeler, A.J., Sav, A., King, M.A., Whitty, J.A., Kendall, E., Kelly, F. (2013). Community pharmacy in Australia: a health hub destination of the future. Research in Social and Administrative Pharmacy, 9(6), 863-875. [CrossRef]
45. 45. Taylor, J., Krska, J., Mackridge, A. (2012). A community pharmacy-based cardiovascular screening service: Views of service users and the public. International Journal of Pharmacy Practice, 20(5), 277-284. [CrossRef]
46. 46. Anderson, C., Blenkinsopp, A., Armstrong, M. (2004). Feedback from community pharmacy users on the contribution of community pharmacy to improving the public's health: A systematic review of the peer reviewed and non‐peer reviewed literature 1990-2002. Health Expectations, 7(3), 191-202. [CrossRef]
47. 47. Jackson, J.K., Sweidan, M., Spinks, J.M., Snell, B., Duncan, G.J. (2004). Public health-recognising the role of Australian pharmacists. Journal of Pharmacy Practice and Research, 34, 290-292.
48. 48. Benrimoj, S.I., Frommer, M.S. (2004). Community pharmacy in Australia. Australian Health Review, 28(2), 238-246.
49. 49. Rutter, V., Chan, A.H.Y., Tuck, C., Bader, L., Babar, Z.U.D., Bates, I. (2018). Weaving the health and pharmaceutical care agenda through the themes of the commonwealth heads of government meeting (CHOGM), London 2018. Journal of Pharmaceutical Policy and Practice, 11(1), 1-4. [CrossRef]
50. 50. Al-Quteimat, O.M., Amer, A.M. (2021). SARS-CoV-2 outbreak: How can pharmacists help? Research in Social and Administrative Pharmacy, 17(2), 480-482. [CrossRef]
51. 51. Bukhari, N., Rasheed, H., Nayyer, B., Babar, Z.U.D. (2020). Pharmacists at the frontline beating the COVID-19 pandemic. Journal of Pharmaceutical Policy and Practice, 13(1), 1-4. [CrossRef]
52. 52. Zheng, S.Q., Yang, L., Zhou, P.X., Li, H.B., Liu, F., Zhao, R.S. (2021). Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective. Research in Social and Administrative Pharmacy, 17(1), 1819-1824. [CrossRef]
53. 53. Um, I.S., Armour, C., Krass, I., Gill, T., Chaar, B.B. (2014). Consumer perspectives about weight management services in a community pharmacy setting in NSW, Australia. Health Expectations, 17(4), 579-592. [CrossRef]
54. 54. Perepelkin, J. (2011). Public opinion of pharmacists and pharmacist prescribing. Canadian Pharmacists Journal/Revue des Pharmaciens du Canada, 144(2), 86-93.
55. 55. Peterson, G.M., Jackson, S.L., Hughes, J.D., Fitzmaurice, K.D., Murphy, L.E. (2010). Public perceptions of the role of Australian pharmacists in cardiovascular disease. Journal of Clinical Pharmacy and Therapeutics, 35(6), 671-677. [CrossRef]
56. 56. Ilardo, M.L., Speciale, A. (2020). The community pharmacist: Perceived barriers and patient-centered care communication. International Journal of Environmental Research and Public Health, 17(2), 536. [CrossRef]
57. 57. Dolovich, L., Austin, Z., Waite, N., Chang, F., Farrell, B., Grindrod, K., Sproule, B. (2019). Pharmacy in the 21st century: Enhancing the impact of the profession of pharmacy on people’s lives in the context of health care trends, evidence and policies. Canadian Pharmacists Journal/Revue Des Pharmaciens Du Canada, 152(1), 45-53. [CrossRef]
58. 58. Bell, J., Dziekan, G., Pollack, C., Mahachai, V. (2016). Self-care in the twenty first century: A vital role for the pharmacist. Advances in Therapy, 33, 1691-1703. [CrossRef]
59. 59. Hughes, C.A., Breault, R.R., Hicks, D., Schindel, T.J. (2017). Positioning pharmacists’ roles in primary health care: A discourse analysis of the compensation plan in Alberta, Canada. BMC Health Services Research, 17, 1-12. [CrossRef]
60. 60. Tsuyuki, R.T., Beahm, N.P., Okada, H., Al Hamarneh, Y.N. (2018). Pharmacists as accessible primary health care providers: Review of the evidence. Canadian Pharmacists Journal/Revue des Pharmaciens du Canada, 151(1), 4-5. [CrossRef]
61. 61. Snyder, J.M., Ahmed-Sarwar, N., Gardiner, C., Burke, E.S. (2020). Community pharmacist collaboration with a primary care clinic to improve diabetes care. Journal of the American Pharmacists Association, 60(3), 84-90. [CrossRef]
62. 62. Tonna, A.P., Stewart, D., West, B., McCaig, D. (2007). Pharmacist prescribing in the UK-a literature review of current practice and research. Journal of Clinical Pharmacy and Therapeutics, 32(6), 545-556. [CrossRef]
63. 63. FIP Vision and mission Web site. (2020). Retrieved August 3, 2023, from https://www.fip.org/vision-mission. Erişim Tarihi: 27.08.2023.
64. 64. Schindel, T.J., Breault, R.R., Hughes, C.A. (2019). “It made a difference to me”: A comparative case study of community pharmacists’ care planning services in primary health care. Pharmacy, 7(3), 90. [CrossRef]
65. 65. Hindi, A.M., Schafheutle, E.I., Jacobs, S. (2019). Community pharmacy integration within the primary care pathway for people with long-term conditions: a focus group study of patients’, pharmacists’ and GPs’ experiences and expectations. BMC Family Practice, 20(1), 1-15. [CrossRef]
66. 66. Policarpo, V., Romano, S., António, J.H., Correia, T.S., Costa, S. (2019). A new model for pharmacies? Insights from a quantitative study regarding the public’s perceptions. BMC Health Services Research, 19, 1-11. [CrossRef]
67. 67. Feehan, M., Walsh, M., Godin, J., Sundwall, D., Munger, M.A. (2017). Patient preferences for healthcare delivery through community pharmacy settings in the USA: A discrete choice study. Journal of Clinical Pharmacy and Therapeutics, 42(6), 738-749. [CrossRef]
68. 68. Benrimoj, S.I., Fernandez-Llimos, F. (2020). An international series on the integration of community pharmacy in primary health care. Pharmacy Practice (Granada), 18(1), 1878. [CrossRef]
69. 69. Yuan, C., Ding, Y., Zhou, K., Huang, Y., Xi, X. (2019). Clinical outcomes of community pharmacy services: A systematic review and meta‐analysis. Health & Social Care in the Community, 27(5), e567-e587.
70. 70. Durham, M.J., Goad, J.A., Neinstein, L.S., Lou, M. (2011). A comparison of pharmacist travel‐health specialists' versus primary care providers' recommendations for travel‐related medications, vaccinations, and patient compliance in a college health setting. Journal of Travel Medicine, 18(1), 20-25. [CrossRef]
71. 71. Costa, F.A., Scullin, C., Al‐Taani, G., Hawwa, A.F., Anderson, C., Bezverhni, Z., Westerlund, T. (2017). Provision of pharmaceutical care by community pharmacists across Europe: Is it developing and spreading? Journal of Evaluation in Clinical Practice, 23(6), 1336-1347. [CrossRef]
72. 72. Eldooma, I., Maatoug, M., Yousif, M. (2023). Pharmaceutical care within community pharmacies: Tools availability and pharmacists’ views, Wad-Medani, Sudan. Integrated Pharmacy Research and Practice, 12, 37-47. [CrossRef]
73. 73. Heath Workforce Australia (2013). Health professionals prescribing pathway (HPPP) project-final report. From http://www.hwa.gov.au/sites/uploads/HPPP-Final-Report-November-2013.pdf. Erişim Tarihi: 26.08.2023.
74. 74. Bhanbhro, S., Drennan, V.M., Grant, R., Harris, R. (2011). Assessing the contribution of prescribing in primary care by nurses and professionals allied to medicine: A systematic review of literature. BMC Health Services Research, 11(1), 1-10. [CrossRef]
75. 75. Stewart, D. (2009). Pharmacist prescribing: A view from the UK. Journal of Pharmacy Practice and Research, 39(1), 7-10.
76. 76. Mann, C., Anderson, C., Avery, A.J., Waring, J., Boyd, M.J. (2018). Clinical pharmacists in general practice pilot scheme: Independent Evaluation Report, from https://www.nottingham.ac.uk/pharmacy/documents/generalpracticeyearfwdrev/clinical-pharmacists-in-general-practice-pilot-scheme-exec-summary.pdf. Erişim Tarihi: 26.08.2023.
77. 77. Bradley, F., Seston, E., Mannall, C., Cutts, C. (2018). Evolution of the general practice pharmacist’s role in England: a longitudinal study. British Journal of General Practice, 68(675), 727-734. [CrossRef]
78. 78. Hann, M., Schafheutle, E.I., Bradley, F., Elvey, R., Wagner, A., Halsall, D., Hassell, K., Jacobs, S. (2017). Organisational and extraorganisational determinants of volume of service delivery by English community pharmacies: a cross-sectional survey and secondary data analysis. BMJ Open, 7(10), e017843. [CrossRef]
79. 79. Elliott, R.A., Boyd, M.J., Salema, N.E., Davies, J., Barber, N., Mehta, R.L., Craig, C. (2016). Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: A pragmatic randomised controlled trial of the New Medicine Service. BMJ Quality & Safety, 25(10), 747-758. [CrossRef]
80. 80. Paudyal, V., Watson, M.C., Sach, T., Porteous, T., Bond, C.M., Wright, D.J., Cleland, J., Barton, G., Holland, R. (2013). Are pharmacy-based minor ailment schemes a substitute for other service providers? British Journal of General Practice, 63(612), 472-481. [CrossRef]
81. 81. Terry, D., Ganasan, S., Aiello, M., Huynh, C., Wilkie, V., Hughes, E. (2021). Pharmacists in advanced clinical practice roles in emergency departments (PARED). International Journal of Clinical Pharmacy, 43(6), 1523-1532. [CrossRef]
82. 82. Seston, E.M., Magola, E., Bower, P., Chen, L.C., Jacobs, S., Lewis, P.J., Steinke, D., Willis, S.C., Schafheutle, E.I. (2020). Supporting patients with long‐term conditions in the community: Evaluation of the greater Manchester community pharmacy care plan service. Health & Social Care in the Community, 28(5), 1671-1687. [CrossRef]
83. 83. Twigg, M.J., Wright, D., Barton, G., Kirkdale, C.L., Thornley, T. (2019). The pharmacy care plan service: Evaluation and estimate of cost-effectiveness. Research in Social and Administrative Pharmacy, 15(1), 84-92. [CrossRef]
84. 84. Nichols, J., England, R., Holliday, S., Newton, J.L. (2019). Clinical care pharmacists in urgent care in North East England: A qualitative study of experiences after implementation. Pharmacy, 7(3), 114. [CrossRef]
85. 85. Wright, D., Twigg, M., Barton, G., Thornley, T., Kerr, C. (2015). An evaluation of a multi-site community pharmacy-based chronic obstructive pulmonary disease support service. International Journal of Pharmacy Practice, 23(1), 36-43. [CrossRef]
86. 86. Crilly, P., Patel, N., Ogunrinde, A., Berko, D., Kayyali, R. (2017). Community pharmacists’ involvement in research in the United Kingdom. Pharmacy, 5(3), 48. [CrossRef]
87. 87. Roberts, A., Marshall, L., Charlesworth, A. (2012). A decade of austerity? The funding pressures facing the NHS from 2010/11 to 2021/22, from https://www.nuffieldtrust.org.uk/research/a-decade-of-austerity-the-funding-pressures-facing-the-nhs-from-2010-11-to-2021-22. Erişim Tarihi: 26.08.2023.
88. 88. NHS England Web site. (2019). From https://www.england.nhs.uk/primary-care/pharmacy/pharmacy-integration-fund/community-pharmacist-consultation-service/ Erişim Tarihi: 27.08.2023.
89. 89. Seston, E.M., Schafheutle, E.I., Willis, S.C. (2022). “A little bit more looking… listening and feeling” A qualitative interview study exploring advanced clinical practice in primary care and community pharmacy. International Journal of Clinical Pharmacy, 44(2), 1-8. [CrossRef]
90. 90. NHS Pharmacy First Scotland Web site. (2020). From https://www.npa.co.uk/news-and-events/news-item/nhs-pharmacy-first-plus-scotland-service/. Erişim Tarihi: 27.08.2023.
91. 91. Basheti, I.A., Mhaidat, N.M., Al-Qudah, R., Nassar, R., Othman, B. (2020). Primary health care policy and vision for community pharmacy and pharmacists in Jordan. Pharmacy Practice, 18(4), 2184. [CrossRef]
92. 92. Ministry of Health Hashemite Kingdom of Jordan We Site (2020). From https://www.moh.gov.jo/. Erişim Tarihi: 23.08.2023.
93. 93. Al-Wazaify, M., Matowe, L., Albsoul-Younes, A., Al-Omran, O. (2006). Pharmacy education in Jordan, Saudi Arabia, and Kuwait. American Journal of Pharmaceutical Education, 70(1), 1-18.
94. 94. Song, Z., Hu, Y., Zheng, S., Yang, L., Zhao, R. (2021). Hospital pharmacists’ pharmaceutical care for hospitalized patients with COVID-19: Recommendations and guidance from clinical experience. Research in Social and Administrative Pharmacy, 17(1), 2027-2031. [CrossRef]
95. 95. Adunlin, G., Murphy, P.Z., Manis, M. (2021). COVID‐19: How can rural community pharmacies respond to the outbreak? The Journal of Rural Health, 37(1), 153-155. [CrossRef]
96. 96. Watson, K.E., Van Haaften, D., Horon, K., Tsuyuki, R.T. (2020). The evolution of pharmacists’ roles in disasters, from logistics to assessing and prescribing. Canadian Pharmacists Journal/Revue des Pharmaciens du Canada, 153(3), 129-131. [CrossRef]
97. 97. Watson, K.E., Singleton, J.A., Tippett, V., Nissen, L.M. (2019). Defining pharmacists' roles in disasters: A Delphi study. PloS One, 14(12), e0227132. [CrossRef]
98. 98. Miller, S., Patel, N., Vadala, T., Abrons, J., Cerulli, J. (2012). Defining the pharmacist role in the pandemic outbreak of novel H1N1 influenza. Journal of the American Pharmacists Association, 52(6), 763-767.
99. 99. Durand, C., Douriez, E., Chappuis, A., Poulain, F., Yazdanpanah, Y., Lariven, S., Peiffer-Smadja, N. (2022). Contributions and challenges of community pharmacists during the COVID-19 pandemic: A qualitative study. Journal of Pharmaceutical Policy and Practice, 15(1), 43. [CrossRef]
100. 100. Wisner, B., Adams, J., World Health Organization. (2002). Environmental health in emergencies and disasters: a practical guide. Geneva: World Health Organization.
101. 101. TÜİK Web site. (2022a). Adrese dayalı nüfus kayıt sistemi sonuçları. Retrieved Şubat 6, 2023, from https://data.tuik.gov.tr/Bulten/Index?p=49685. Erişim Tarihi: 28.08.2023.
102. 102. TÜİK Web site. (2023). Dünya nüfus günü, 2023. Retrieved Temmuz 6, 2023, from https://data.tuik.gov.tr/Bulten/Index?p=Dunya-Nufus-Gunu-2023-49688. Erişim Tarihi: 28.08.2023.
103. 103. TÜİK Web site. (2022b). Sağlık harcamaları istatistikleri. Retrieved Aralık 7, 2022, from https://data.tuik.gov.tr/Bulten/Index?p=Health-Expenditure-Statistics-2021-45728. Erişim Tarihi: 28.08.2023.
104. 104. Daştan, İ., Çetinkaya, V. (2015). OECD ülkeleri ve Türkiye’nin sağlık sistemleri, sağlık harcamaları ve sağlık göstergeleri karşılaştırması. Sosyal Güvenlik Dergisi, 5(1), 104 134.
105. 105. Pekten, A. (2006). Genel sağlık sigortası sistemi ve getirdiği yenilikler. Sayıştay Dergisi, 61, 119-138.
106. 106. Sağlık Bakanlığı (2019). T.C. Sağlık Bakanlığı Sağlık Hizmetleri Genel Müdürlüğü, 31.05.2019 tarihli, 2019/10 sayılı “Sağlık Hizmeti Sunucularının Basamaklandırılması” Genelgesi. Sağlık Bakanlığı, Ankara.
107. 107. Sağlık Bakanlığı (2023). Sağlık istatistikleri yıllığı 2021. TC Sağlık Bakanlığı: Ankara. https://www.saglik.gov.tr/Eklenti/45316/0/siy2021-turkcepdf.pdf. Erişim tarihi: 28.08.2023.
108. 108. Toklu, H., Akici, A., Oktay, Ş., Sanda, C.A.L.İ., Sezen, S., Uysal, M.K. (2010). The pharmacy practice of community pharmacists in Turkey. Marmara Pharmaceutical Journal, 14(1), 53-60.
109. 109. Okuyan, B., Ozcan, V., Balta, E., Durak-Albayrak, O., Turker, M., Sancar, M., Yavuz, B.B., Uner, S., Ozcebe, H. (2021). The impact of community pharmacists on older adults in Turkey. Journal of the American Pharmacists Association, 61(6), 83-92. [CrossRef]